Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.360
-0.010 (-0.73%)
At close: Feb 21, 2025, 4:00 PM
1.350
-0.010 (-0.71%)
After-hours: Feb 21, 2025, 6:48 PM EST
Enveric Biosciences Employees
Enveric Biosciences had 7 employees as of December 31, 2023. The number of employees decreased by 19 or -73.08% compared to the previous year.
Employees
7
Change (1Y)
-19
Growth (1Y)
-73.08%
Revenue / Employee
n/a
Profits / Employee
-$1,408,040
Market Cap
2.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | -19 | -73.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | 21 | 700.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ENVB News
- 18 days ago - Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease - Business Wire
- 19 days ago - Enveric Biosciences Announces Closing of $5 Million Public Offering - Business Wire
- 23 days ago - Enveric Biosciences Announces Pricing of $5 Million Public Offering - Business Wire
- 23 days ago - Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office - Business Wire
- 6 weeks ago - Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025” - Business Wire
- 2 months ago - Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds - Business Wire
- 3 months ago - Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior - Business Wire
- 3 months ago - Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results - Business Wire